“Circulating Fibroblast Growth Factor-23 Is Associated With Increased Risk for Metachronous Colorectal Adenoma”. Journal of Carcinogenesis 10, no. 1 (February 22, 2011). Accessed December 8, 2025. https://carcinogenesis.com/index.php/JOC/article/view/146.